Merck Millipore to advance industry best practice in China
Collaborates with Peking University
Merck Millipore, the life science division of Merck KGaA, is to serve on the faculty of the Centre for Pharmaceutical Information and Engineering Research (CPIER) at Peking University in China.
The programme, established in 2006 with the US FDA, relies on faculty from industry partners to prepare master’s degree candidates in its international pharmaceutical engineering programme.
‘It’s a privilege for Merck Millipore to collaborate with top pharmaceutical companies and regulators in delivering a curriculum to advance industry best practices in China,’ said Jean-Paul Mangeolle, head of Merck Millipore’s Process Solutions business. ‘Our expertise will help ensure that education focuses on the quality and safety of products – made and consumed locally – in the years to come.’
The CPIER’s education program has a faculty of around 80 lecturers and 170 master’s degree students who work at manager-level positions in the biopharmaceutical industry.
Merck Millipore, the only filtration and separation company invited to participate in the master’s course, will teach a module on quality and production processes, focusing on sterilising filtration, aseptic processing and critical filter validation.
In 2011, Merck Millipore opened a Biopharmaceutical Technical and Training Centre in Shanghai, reinforcing its commitment to support the production of safe, quality drugs in the region. CPIER will use the centre for GMP and aseptic process manufacturing training.
